Apararenone
- Generic Name
- Apararenone
- Drug Type
- Small Molecule
- Chemical Formula
- C17H17FN2O4S
- CAS Number
- 945966-46-1
- Unique Ingredient Identifier
- 832663U2NB
- Background
Apararenone is under investigation in clinical trial NCT02531568 (Drug Interaction Study of Warfarin and MT-3995).
Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 48
- Registration Number
- NCT02923154
- Locations
- 🇯🇵
Investigational site, Osaka, Japan
Mass Balance Study of MT-3995
- First Posted Date
- 2016-09-14
- Last Posted Date
- 2017-01-31
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 9
- Registration Number
- NCT02900235
- Locations
- 🇬🇧
Investigational center, City name, United Kingdom
Drug Interaction Study of Warfarin and MT-3995
- First Posted Date
- 2015-08-24
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT02531568
- Locations
- 🇩🇪
Clinical research organization, Neu-Ulm, Wegenerstraße, Germany
Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy
- First Posted Date
- 2014-07-31
- Last Posted Date
- 2015-09-16
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 31
- Registration Number
- NCT02205372
- Locations
- 🇯🇵
Touei Hospital, Sapporo, Hokkaido, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath